Aguilar, Ghirl An L.
HRN: 21-64-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/30/2022
IV
1.5 Gm
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes